Skip to content
Open access · CC-BY via OpenAlex

Umbilical cord-derived mesenchymal stem cells: Their advantages and potential clinical utility

Tokiko Nagamura‐Inoue

World Journal of Stem Cells · 2014 · ▲ 491 citations

Abstract

Human umbilical cord (UC) is a promising source of mesenchymal stem cells (MSCs). Apart from their prominent advantages, such as a painless collection procedure and faster self-renewal, UC-MSCs have shown the ability to differentiate into three germ layers, to accumulate in damaged tissue or inflamed regions, to promote tissue repair, and to modulate immune response. There are diverse protocols and culture methods for the isolation of MSCs from the various compartments of UC, such as Wharton's jelly, vein, arteries, UC lining and subamnion and perivascular regions. In this review, we give a brief introduction to various compartments of UC as a source of MSCs and emphasize the potential clinical utility of UC-MSCs for regenerative medicine and immunotherapy.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.4252/wjsc.v6.i2.195
Canonical
link ↗
Fetched
2026-06-24 MST

Cite this

APA
Nagamura‐Inoue, T. (2014). Umbilical cord-derived mesenchymal stem cells: Their advantages and potential clinical utility. <em>World Journal of Stem Cells</em>. https://doi.org/10.4252/wjsc.v6.i2.195
Vancouver
Nagamura‐Inoue T. Umbilical cord-derived mesenchymal stem cells: Their advantages and potential clinical utility. World Journal of Stem Cells. 2014. doi:10.4252/wjsc.v6.i2.195.
BibTeX
@article{tokiko2014Umbili, title = {Umbilical cord-derived mesenchymal stem cells: Their advantages and potential clinical utility}, author = {Tokiko Nagamura‐Inoue}, journal = {World Journal of Stem Cells}, year = {2014}, doi = {10.4252/wjsc.v6.i2.195}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings